|
We recommend colistin inhalation therapy for cystic fibrosis patients with chronic P. aeruginosa lung infection as a supplementary treatment to frequent courses of intravenous anti-pseudomonas chemotherapy.
|
jac.oxfordjournals.org/cgi/content/abstract/19/6/831
|
|
|
|
|
colistin methanesulphonate in patients with cystic fibrosis .... Keywords: cystic fibrosis, colistin methanesulphonate, colistin,. Pseudomonas spp. ...
|
jac.oxfordjournals.org/cgi/reprint/58/1/222.pdf
|
|
|
|
Patients ranged in age from 14 to 53 years and received colistin for 6 to 35 days. Each patient was started on colistin 5 to 7 mg/kg/day ... Pharmacokinetics of inhaled colistin in patients with cystic fibrosis; J. Antimicrob. Chemother., February 1, 2006; 57(2): 306 - 311. [Abstract] [Full Text] [PDF];
|
jcp.sagepub.com/cgi/content/abstract/41/6/645
|
|
|
Find out all about colistin cystic fibrosis, including the most common uses, side effects, interactions and risk factors from leading medical experts. ... Members related to colistin cystic fibrosis...
|
www.wellsphere.com/wellpage/colistin-cystic-fibrosis
www.wellsphere.com/wellpage/colistin-cystic-fibrosis
|
|
June 29, 2007 — A potential link between inhalation of premixed colistimethate liquid via nebulizer and the death of a patient with cystic fibrosis (CF) is being investigated, the US Food and ... However, the mixing of colistimethate with water allows spontaneous hydrolysis of the drug to its bioactive form colistin,
|
www.medscape.com/viewarticle/559135
|
|
Tobramycin nebuliser solution significantly improved lung function of patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa, but colistin did not, in this study of 1-month's duration. Both treatments reduced the bacterial load.
|
www.medscape.com/medline/abstract/12358344
|
|
Keywords: colistin, cystic fibrosis, Pseudomonas aeruginosa, tobramycin ... Tobramycin nebuliser solution significantly improved lung function of patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa, but colistin did not, in this study of 1-month's duration. Both treatments reduced the bacterial load.
|
erj.ersjournals.com/cgi/content/abstract/20/3/658
|
|
CONCLUSIONS: Intravenous colistin is an effective treatment for Pseudomonas aeruginosa associated pulmonary exacerbations in patients with cystic fibrosis. ...
|
www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1758...
www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1758447
|
|
It appears that intravenous colistin can be considered for cystic fibrosis patients with strains of P. aeruginosa that are resistant to more commonly used antibiotics. ... Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients; J. Antimicrob.
|
www.theannals.com/cgi/content/abstract/25/11/1168
|
|
